Antibacterial and Pharmacological Evaluation of Root Extract of Plant
Achyranthes aspera (Amaranthaceae)
Amalesh Samanta*, Aditya Kumar Jena, Chandrima Sinha, Soma Ghosh and Anurup Mandal
Division of Microbiology, Dept. of Pharmaceutical Technology, Jadavpur University, Kolkata-700 032, India
*Corresponding Author E-mail: asamanta61@yahoo.co.in
ABSTRACT:
Medicinal plants are important elements of indigenous medical system. Achyranthes aspera (family Amaranthaceae) is a plant with enormous medicinal values. The root, leaf, stem of this plant is traditionally used by the folks for treatment of a large number of diseases in different parts of the world. The aqueous extract and the methanol extract of the root contain alkaloid, steroid, terpenoid, flavonoid, saponin and reducing sugars. The toxicity studies showed the methanolic extracts are safe up to the concentration of 400 mg/mL. Both the extracts at a dose of 100 mg/mL showed significant reduction in body temperature in yeast induced pyrexia and marked reduction in plasma glucose level when tested on Wister albino rats. At the same dose level the extracts also showed significant anti-inflammatory activity on carrageenan and dextran induced rat paw edema. The methanol extract when tested against 12 different bacterial strains ( including both gram negative and gram positive bacteria), it gave MIC values at 1.2 mg/mL and 1.6 mg/mL for Shigella dysenteriae 6 and Shigella dysenteriae 8 respectively where other bacterial strains were resistant to the extract. All the results support the traditional claim of the effectiveness of this medicinal herb in different ailments, infections, pyrexia, diabetes and other diseases.
KEYWORDS: Achyranthes aspera, phyto-chemical study, pharmacological activity, antibacterial activity
1. INTRODUCTION:
Traditional herbal medicine has a long history of serving mankind all over the world. Achyranthes aspera, family Amaranthaceae, is found throughout the tropical Asia, Africa, Australia and America from the seashore to 2,100 m height. It is an annual or perennial herb. Different parts of the plant are reported to have great medicinal importance for gynecological disorders1, diabetes2,3, different infections4,5 and other diseases. Decoction of the root of the plant are reported to be used as antibacterials6 and different gynecological disorders7,8. The aim of our present work is to identify the different phyto-constituents in different solvent extracts of roots of Achyranthes aspera by different phyto chemical tests. The toxicity study for the methanol extract of the root was performed for safety purpose. The traditional uses of the root extract as anti inflammatory, anti pyretic, anti diabetic and antimicrobial agent also have been established by using different in vivo and in vitro models.
2. MATERIAL AND METHODS:
2.1. Plant material and extraction procedure:
The roots of Achyranthes aspera were dried in a drier for two days at 40şC, crushed in a mechanical grinder to fine powder of mesh 40. The powder (500 g) was then extracted successively with petroleum ether, methanol and water in a Soxhlet apparatus. The extracts were filtered and the solvents were evaporated to dryness under reduced pressure in an Eyela Rotary Evaporator (Japan) at 40–45 °C. The yields are 1.25% and 3.46% w/w respectively for methanol and aqueous extracts.
2.2. Phytochemical identification:
The predominant phytochemicals in the root extracts were identified as per the standard qualitative methods9, 10.
2.3. Animal used:
Swiss albino mice weighing between 18-20 g were used for toxicity study. Adult albino rats of either sex weighing 180–200 g each were used for other pharmacological studies. The animals were housed in standard polypropylene cages at room temperature and provided with standard pellet diet and water ad libitum.
Animal experiments were conducted following the guidelines of the institutional animal ethics committee.
2.4. Micro organism used:
A total of 12 strains of bacteria comprising of 2 gram-positive and 10 gram-negative genera were tested. They were isolated mostly as human pathogens and subjected to stringent culture. Isolates were identified by the methods of Barrow and Feltham11,12 and were preserved in the freeze-dried state as well as at 40C in stab slant agar. All bacterial strains are preserved in the Division of Microbiology, Dept. of Pharmaceutical Technology, Jadavpur University, Kolkata-32, West Bengal, India.
2.5. In vivo toxicity study:
The mice were randomly divided into experimental groups and a control group, with 10 animals in each group, and kept in polypropylene cage, which received different doses of methanol root extract in intra-peritoneal (I.P) route. Control animals received aqueous tween80 solution 2 %( v/v) and the experimental groups received methanol extract at doses of 50-400 mg/kg body weight of mice, administered through IP route 13. After administration of the extract by the I.P route the animals were observed under open field condition for 72 hours and the number of deaths and signs of clinical toxicity were recorded.
2.6. In vivo anti pyretic activity study:
2.6.1. Study on normal body temperature
Four groups of six animals were taken. The body temperature of each rat was measured rectally at 0, 1.5 and 3 h after administration of distilled water (control) methanol and aqueous fractions at a dose of 100mg/kg body wt. orally.
2.6.2 Study on yeast-induced pyrexia
Rats were divided into four groups of six rats each. Fever was induced 14. Animals were given a subcutaneous injection of 10 mL/kg body wt. of 15 % w/v yeast suspended in 0.5% w/v methylcellulose solution. After 19 h of yeast injection, the animals were restrained in individual cages for the recording of their rectal temperatures by insertion of a thermocouple to a depth of 2 cm into rectum. Elevation of body temperature ensures the induction of pyrexia
19 hrs after yeast injection the different fractions of Achyranthes aspera root extracts were administered orally at the dose of 100 mg/kg body weight into two groups of animal. One group of animal was treated with distilled water (10ml/kg body weight) and serve as control group. The fourth group of rats received the standard antipyretic drug paracetamol at a dose of 150 mg/kg body weight orally. Rats were restrained for recording the rectal temperature, which was recorded at 19, 21 and 23 hrs.
2.7. In vivo anti-inflammatory activity study:
2.7.1. Carrageenan-induced rat paw edema:
Edema was induced by sub-planter injection of 0.1 ml of 1% freshly prepared suspension of carrageenan (Sigma Chemical Co., USA) to each animal of four groups. The different extracts were suspended in 0.03% tween80 solution. The test groups received the extract (100 mg/kg body weight; orally), standard group received Indomethacin (25 mg/kg body weight; orally) and control group received the vehicle only. All the doses were given orally 30 minutes prior to the injection of carrageenann. The volume of the injected and contra-lateral paws was measured after 4 hours of carrageenan administration. Normal paw volume also noted at 0th hour i.e. before carrageenan injection. Inflammation was expressed in terms of paw edema by volume of water displaced by the inflammated rat paw in Plethysmometer15.
2.7.2. Dextran-induced rat paw edema:
The dextran induced rat paw edema test was performed according to the standard method16. This study was carried out in a similar manner of carrageenan induced paw edema model. Dextran (0.1 ml, 1% w/v in normal saline) was used in place of carrageenan.
The percentage inhibition of paw edema was calculated for both models17.
2.8. Oral glucose tolerance test (OGTT):
The oral glucose tolerance test 18 was performed in overnight fasted (18 h) normal rats. Rats divided into three groups (n = 6) were orally administered distilled water(10ml/kg body weight), methanol extract and aqueous extract of Achyranthes aspera (100 mg/kg body weight). Glucose (2 g/kg body weight) was fed orally, 30 min prior to the administration of extracts. Blood was withdrawn from the tail vein and the glucose level was measured at 0th, 1st, and 2nd hour with the help of single touch glucometer.
2.9. In vitro screening for the detection of antibacterial activity:
MIC was determined by agar dilution method19 and disk diffusion method20. For this study sterile nutrient agar base was taken to which dried methanol root extract was added at such concentrations that the final concentration contain 0 (control), 100, 200, 400, 800, 1200 and 1600 g of extract in 1.0 mL of medium. The volume of nutrient agar medium poured in 80 mm Petri dishes was 20 mL.
The standard inoculums for determination of MIC with respect to various bacteria consisted of one loop full of overnight peptone water culture of the test organism21. The plates were incubated at 37˚C and examined after 24 h and incubated further for 72 h, if necessary. The MIC was defined as the lowest concentration of an antibiotic or a chemotherapeutic agent that completely inhibited the growth of the organism. The MIC test was performed in triplicate for each organism and the experiment was repeated where necessary.
2.10. Statistical Analysis:
The results were expressed as mean±SEM. The significance was evaluated by Student’s t-test compared with control22.
3. RESULTS:
3.1. Phytochemical analysis:
Table-1 shows the petroleum ether extract of the root contain only the steroids and triterpenoid whereas the methanol and aqueous extract contains alkaloids, steroid, triterpenoid, flavonoid, tannin, saponin and reducing sugar.
Table 1. An over view of chemical constituents present in various extracts of Achyranthes aspera root
|
Extracts |
Alkaloid |
Anthraquinone glycoside |
Steriod |
Triterpenoid |
Flavonoid |
Tannin |
Saponin |
Reducing Sugar |
|
Petroleum ether (60-80°C) |
- |
- |
+ |
+ |
- |
- |
- |
- |
|
Methanol |
+ |
- |
+ |
+ |
+ |
+ |
+ |
+ |
|
Aqueous |
+ |
- |
+ |
+ |
+ |
+ |
+ |
+ |
“+” sign indicates presence and “-” sign indicates absence
3.2. Toxicity study:
Table-2 shows that the methanol extract of the roots is safe up to dose 400 mg/kg body weight when tested with Swiss albino mice.
Table 2: The toxicity study of the methanol extract of Achyranthes aspera administered Intra peritonealy in albino mice
|
Treatment
|
Dose (mg/kg) |
No. of animals used |
No. of survival |
No. of death |
|
Control |
0 |
20 |
20 |
00 |
|
Methanol Extract
|
50 |
20 |
20 |
00 |
|
100 |
20 |
20 |
00 |
|
|
150 |
20 |
20 |
00 |
|
|
200 |
20 |
20 |
00 |
|
|
250 |
20 |
20 |
00 |
|
|
300 |
20 |
20 |
00 |
|
|
350 |
20 |
20 |
00 |
|
|
400 |
20 |
20 |
00 |
3.3. Antipyretic activity:
From Table-3 and Table-4 it was found that the methanol extract of the root possesses a significant action in maintaining the normal body temperature and reduces the yeast induced elevated temperature in albino rats and their effect are comparable to that of the standard antipyretic drug, paracetamol.
Table3. Effect of Achyranthes aspera root extract on normal body temperature in albino rats
|
Treatment |
Rectal temperature (ş F) before and after treatment |
||
|
0 h |
1.5 h |
3h |
|
|
Normal (0mgl/kg) |
98.2±0.4041
|
98.2±0.2309
|
98.7±0.1155
|
|
Methanol (100 mg/kg) |
98.3±0.4910* |
97.46±0.5696* |
97.5±0.2887* |
|
Aqueous (100 mg/kg) |
98.26±0.9821* |
96.73±0.5925* |
96.86±0.4096* |
|
Paracetamol (150 mg/kg) |
98.26±0.1764* |
97.13±0.1764* |
97.2±0.1155* |
Each value represents mean ± S.E.M. (n=6), * p< 0.05, with respect to control
Table 4. Effect of Achyranthes aspera root extracts on Yeast induced pyrexia in albino rats
|
Treatment |
Rectal temperature (ş F) after yeast injection |
||
|
19 h |
21 h |
23h |
|
|
Control (0mgl/kg) |
100.93±0.6566 |
99.63±0.088 |
98.96±0.260 |
|
Methanol (100 mg/kg) |
99.23±0.0881* |
97.933±0.260* |
97.166±0.523* |
|
Aqueous (100 mg/kg) |
99.2±0.4163* |
98.16±0.233* |
98.066±0.348* |
|
Paracetamol (150 mg/kg) |
98.53±0.1453** |
96.266±0.536** |
95.93±0.290** |
Each value represents mean ± S.E.M. (n=6). ** p< 0.01, with respect to control; *p<0.05, with respect to control
3.4. Effect on Carrageenan-induced and Dextran-induced rat paw edema:
The results obtained for methanol and aqueous extracts of root of Achyranthes aspera on carrageenan and dextran induced rat paw edema are shown in Table-5 and Table-6 respectively. The extracts significantly (p<0.001) inhibited the inflammatory edema at a dose of 100mg/ kg body weight of rat. The inhibition was highest for methanol extract. The percentages of inhibition of methanol extract for Carrageenan and Dextran induced paw edema are 66.99 and 69.81 respectively. Results were compared to that of the Indomethacin a non- steroidal anti-inflammatory drug.
3.5. Oral glucose tolerance test:
In oral glucose tolerance test, the extract, at 1st hr, showed significant reduction in plasma glucose level indicated in Table-7.
In the present study, oral glucose tolerance test (OGTT) was performed in normoglycemic rats. It is observed that methanol extracts and aqueous extracts reduce the blood glucose level more than the control (0.9% Nacl; 5 mL/kg.body weight) when administered orally.
3.6. In vitro antimicrobial study:
From Table-8 it was seen that out of 12 strains tested the MIC values of Achyranthes aspera against Shigella dysenteriae 6 and Shigella dysenteriae 8 were 1.2mg/mL and 1.6mg/mL respectively. Remaining 10 bacterial strains were resistant to the methanol root extracts up to the concentration of 1.6mg/mL.
4. DISCUSSION:
In our study we investigated on different phyto chemical, pharmacological and antibacterial properties of root extracts of plant Achyranthes aspera (Amaranthaceae). Table1. Indicates phytochemicals in the petroleum ether, methanol and aqueous extracts revealed differences in their constituents. Phytochemical compounds such as alkaloids, steroid, triterpenoid, flavonoid, tannin, saponin and reducing sugar are present
The in vivo studies established the profound anti pyretic, anti inflammatory and anti diabetic activity of methanol root extract of Achyranthes aspera with a dose of 100 mg/mL which was found to be safe for the animals by toxicity study (Table 2).
Table 3, 4 shows the effectiveness of the methanolic extract to maintain the normal body temperature and reduce the yeast induced pyrexia to a better extent than the aqueous extracts.
Table 5: Carageenan induced anti-inflammatory model
|
Treatment |
Dose (mg/kg body weight) Orally |
Paw volume in ml |
% Inhibition of edema |
|
Control |
0.03% v/v aqueous tween80 solution |
3.03±0.318 |
0 |
|
Methanol extracts |
100mg/kg |
1±0.115* |
66.99% |
|
Aqueous extracts |
100mg/kg |
1.43±0.145* |
52.80 |
|
Indomethacin |
25mg/kg |
0.83±0.145* |
72.60 |
Each value represents mean ±SEM (n=6), *P< 0.01 with respect to control
Table 6: Dextran induced anti-inflammatory model
|
Treatment |
Dose (mg/kg body weight) Orally |
Paw volume in ml |
% Inhibition of edema |
|
Control |
0.03% v/v aqueous tween80 solution |
3.2±0.208 |
0 |
|
Methanol extracts |
100mg/kg |
0.966±0.218 |
69.81 |
|
Aqueous extracts |
100mg/kg |
1±0.152 |
68.75 |
|
Indomethacin |
25mg/kg |
0.866±0.176 |
72.93 |
Each value represents mean ±SEM (n=6), *P< 0.01 with respect to control
Table 7: Effect of methanol extract of Achyranthes aspera on oral glucose tolerance test (OGTT)
|
Group
|
Treatment |
Plasma glucose concentration (mg/dl) |
||
|
0 hr |
1hr |
2hr |
||
|
I |
Normal control |
91.66±1.66 |
86.66±2.90 |
89±2.08 |
|
II |
Normal + methanol extracts (100mg/kg) |
96.66±1.20* |
68±1.15* |
78.33±1.66* |
|
III |
Normal + aqueous extracts (100mg/kg) |
91.66±10.17* |
63.66±1.20* |
80.66±1.33** |
Values are expressed as mean ± SEM from n=6, * p < 0.05 compared with normal group, **P< 0.01 compared with normal group
Table 8. Effect of methanol root extract of Achyranthes aspera on different groups of bacteria
|
Bacterial strain tested |
Growth in nutrient agar containing different concentration of methanol root extract of Achyranthes aspera (µg/mL) |
||||||
|
0(control)* |
100 µg/mL |
200µg/mL |
400 µg/mL |
800 µg/mL |
1200 µg/mL |
1600 µg/mL |
|
|
Vibrio cholerae DN6 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Psedomanas 25619 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Escherichia coli 55 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Klebsiella pneumonia J/114 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Shigella dysenteriae 6 |
+ |
+ |
+ |
+ |
+ |
– |
– |
|
Shigella flexneri Eo3429 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Shigella sonnei 288 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Shigella boydii 10 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Salmonella typhi NCTC74 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Shigella dysenteriae 8 |
+ |
+ |
+ |
+ |
+ |
+ |
– |
|
Staphylococcus aureus 25923 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Bacillus subtilis UC 564 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
*, control plate without drug; +, growth; –, no growth
Table 5, 6 indicated the profound anti inflammatory activity of the methanol and aqueous extracts when compare with the standard drug. The carrageenan induced paw edema is believed to be biphasic, of which the first phase is mediated by early release of histamine and 5HT followed by the release of kinin in later phase 23. Dextran mediated inflammation (edema) was also mediated by both histamine and serotonin24. The exact mechanism of anti-inflammatory action of root extracts is not evaluated till now but there are many evidences of plant extracts which have this type of effects25, 26. Flavonoids present in the extracts may be responsible for the anti-inflammatory and antipyretic properties due to their inhibitory effects on enzymes involved in the production of the chemical mediators of inflammation and pyrexia 27.
Table 7 reveals the ability of extracts to reduce the normal blood glucose level so they may have a desirable antidiabetic effect consequently. The anti-diabetic effects may be due to the reduction of the intestinal absorption of glucose or may be able to increase the utilization of glucose by tissues28. The results proved the anti-diabetic effect by the administration of methanol and aqueous extracts. This suggests that the possible mechanism of action may resemble as glibenclamide due to a direct stimulation of insulin secretion or delayed glucose absorption.
The in vitro screening for antibacterial activity proved effectiveness of methanol root extract against dysentery at a concentration comparable with other plant extracts containing tannins, flavonoids, saponins, sterols, triterpene and reducing sugars29.
Isolation of active pure compounds and further analytical research on them will help to find out the exact mechanism of action for the pharmacological and antibacterial effects of the root extract of Achyranthes aspera.
ACKNOWLEDGEMENTS:
We are thankful to All India Council for Technical Education (A.I.C.T.E.) for the necessary financial assistance to conduct the work.
We are also grateful to “Botanical Survey of India”, Botanic Garden- Howrah,West Bengal, India. Vide No. CNH/1– 1(44)/2006/Tech.II/996 for the identification of the plant.
REFERENCES:
1. Basu NK, Singh K, Agarwal OP. Chemical investigation of Achyranthes aspera, J Proc Inst Chem.1957; 29(1): 55.
2. Dhar ML et al. J. Exp. Bio. 1968; 5(4): 675-686.
3. El-Kheir, VM, Salik MH. Fitoterpia. 1980; 51(3): 43.
4. Khurana LM, Paul SM, Bhargawa KS, J. Appl. Microbiology. 1970; 16(3): 255.
5. Ikram M, Haq I. Fitoterpia. 1980; 51(5): 231.
6. Rangari VD, Pharmacognocy and Phytochemistry Part II, Ist edition, Carrer publication. 2006; pp. 179-180.
7. Nadkarni KM, Indian Materia Medica , Vol -I, Bombay Popular Prakashan, 2005; pp.21-22.
8. Dwivedi SN. Herbal Remedies among tribals of sidhi district of Madhya Pradesh. J.Econ.Tax. 2004; 28(3): 675-686.
9. Brain KR and TD Turner. The practical evaluation of phytopharmaceuticals. Wright Science Technica Bristol. 1975; 2nd ed: pp. 81.
10. Evans WC. Trease and Evans’ Pharmacognosy. London, England. W.B. Sounders Company limited. 1996; 14th ed: pp. 54.
11. Barrow GI, Feltham RKA. In: Cowan and Steel's Manual of the Identification of Medical Bacteria, Cambridge University Press, Cambridge. 1993; pp. 50–59.
12. Collee FG, Miles RS, Watt B. Tests for identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A. edited by Mackie & McCartney’s practical medical microbiology. NY: Churchill Livingstone, New York, 1996; 14th ed: pp. 131–150.
13. Rodrigues ER., Pedrazzi AHP, Bastos JK, Acute Preclinical Toxicity Study of Zanthoxylum naranjillo Extract. Phytother Res. 1998; 12: 512-516.
14. Murugesan T et al. Evaluation of anti-pyretic potential of Jus-siaeasuffrutucosa Linn. Extract in rats. Phytomed. 2000; 7: 231–234
15. Winter CA, Risley EA, Nuss GW. Carrageenan-induced oedema in hind paws of rat as assay for anti-inflammatory drugs. Exp Bio Med. 1962; 111: 544- 547
16. Parmar NS, Ghosh MN. Anti-inflammatory activity of gossypin bioflavonoid isolated from Hibiscus viofolius Linn. Ind J Pharmacol. 1978; 10: 277-293.
17. Kavimani S et al. Anti-inflammatory activity of the volatile oil of Toddalia asiatica. Ind J Pharm Sci. 1996; 58: 67-70.
18. Weir GC and Weir B. Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. J Clin Invest. 1990; 85(4): 983–987.
19. Chattopadhyay D et al. Altered membrane permeability as the basis of bactericidal action of methdilazine. J Am Chemotherapy. 1998; 42: 83-86.
20. National Committee for Clinical Laboratory Standards(NCCLS), approved standard M7-A3, NCCLS, Villanova, PA, 1993; 3rd Ed.
21. McFarland J Nephelometer: an instrument for estimating the number of bacteria in suspensions used for calculating the opsonic index and for vaccines. J Am Med Assoc. 1907; 49: 176–178.
22. Woodson RF. Statistical Methods for the Analysis of Biomedical Data, Probability and Mathematical Statistics. Wiley, Chichester, UK. 1987; pp. 315-316.
23. Castro J et al. Diverse effect of SKF52 and antioxidants on CCL4 induced changes in liver microsomal P-450 content and ethyl-morphine metabolism. Life Sci. 1968; 7: 129.
24. Ghosh MN, Banerjee RH and Mukherjee SK. Capillary permeability increasing property of hyaluronidase in rat. Ind J Physiol Pharmacol. 1963; 7: 17–21.
25. Tsuruga T et al. Biologically active constituents of Melaleuca leucadendron: inhibitors of induced histamine release from rat mast cells. Chem. Pharm. Bull. 1991; 39(12): 3276–3278.
26. Diaz AM et al. In vitro anti-inflammatory activity of iridoids and triterpenoid compounds isolated from Phillyrea latifolia L. Biol Pharm Bull. 2000; 23 (11): 1307–1313.
27. Oweyele VB et al. Analgesic and anti-inflammatory properties of Nelsonia canescens leaf extract. J Ethnopharm. 2005; 99: 153-156.
28. Sharma M et al. Preliminary phytochemical , anti-inflammatory and antibacterial activity of the leaves of Butea monosperma. Ind J. of Natural products. 1983; 16 (2): 22-24.
29. Chattopadhyay D et al. Antimicrobial activity of Alstonia macrophylla: folklore of bayislands. J Ethnopharm. 2001; 77: 49–55.
Received on 10.03.2010 Modified on 24.03.2010
Accepted on 07.04.2010 © RJPT All right reserved
Research J. Pharm. and Tech.3 (3): July-Sept. 2010; Page 910-914